Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Grant of second patent to Dr. Ashish Rawandale Patil, MD of Tejnaksh Healthcare Ltd for the 5 Part Access Needle

Posted On: 2019-12-06 13:41:39

Dr. Ashish Rawandale Patil has been granted his second patent for the 5 Part Access Needle (5-PANG needle). Dr Ashish Rawandale Patil is the only urologist to have received two patents.

PCNL is a keyhole surgery done to endoscopically remove a stone from the kidney. Conventionally the technique has been described in the Western countries and instruments manufactured by the Western countries are to be used to perform the surgery. Existing instruments have a lot of disadvantages, they are expensive and have to be procured from overseas companies. The 5-PANGPCNL system is an indigenously developed instrument which removes all the drawbacks of the conventionally available foreign instruments, makes PCNL easy to learn, safe to perform and affordable to the patient. Grant of the patent to Dr Ashish would now open a new chapter in PCNL instrumentation giving him and Tejnaksh Healthcare the Liberty of being the sole owner of the intellectual rights to the instrument and the technique. Processes are underway to set up or manufacturing and distribution chain for the instrument.

Advantages of the 5-PANG PCNL:

The 5-PANG PCNL essentially removes/ eliminates all the complications of the conventional PCNL and makes the operation easy to learn for the beginner surgeons. It decreases the bleeding during the surgery. It can be used with ultrasound as well as xray machines and can be used for many cases because it is re-sterilizable. It decreases the radiation time and hence is safe for the patient, doctors and paramedical staff. It saves on the disposables. Hence it makes the whole procedure fast, effective and safe. The technique has also appeared in a recently published textbook of urology (Surgical techniques in Pediatric and Adolescent Urology - Chapter 89).

Patent grant of the 5-PANG PCNL is thus a major landmark in the history of endoscopic removal of the stone/ PCNL. This invention has proved that an instrument made in India is not only more effective then the foreign equipment but at the same time reduces the dependency on overseas companies for the technique and instruments.

Shares of Tejnaksh Healthcare Ltd was last trading in BSE at Rs.57 as compared to the previous close of Rs. 59.8. The total number of shares traded during the day was 100 in over 1 trades.

The stock hit an intraday high of Rs. 57 and intraday low of 57. The net turnover during the day was Rs. 5700.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

IndiGo launches direct connection between Delhi and Bangkok

mBAJA & eBAJA Design and Technical Evaluation and Dynamic Events held today for BAJA SAEINDIA 2020

Wendt India Ltd announces Q3, 9MFY20 results

ABM Knowledgeware Ltd Q3 consolidated net profit slips to Rs. 3.08 crore

Prestige Estates Projects Ltd consolidated Q3 net profit climbs to Rs. 161.8 crore

EIH Ltd Q3 net profit higher QoQ, YoY

Bank of Baroda reports loss in Q3 FY2020

Eldeco Housing and Industries Ltd announces Q3, 9MFY20 results

BEML CMD gets Most Admired Leader Award

Siemens Ltd to acquire 99.22% in C&S Electric Ltd for Rs. 2100 crore

VST Tillers Tractors Ltd enters into MOU with Zetor Tractors

NHPC declared successful resolution applicant for Jalpower Corporation Ltd

L&T raises Rs. 1000 crore through 6.72% NCDs

Solapur Tollways Pvt Ltd receives completion certificate for part of NH-9 project

Cipla gets 4 observations from USFDA for API facility at Bommasandra, Bangalore

ALLSEC Technologies Ltd consolidated Q3 FY20 net profit at Rs. 8.55 crore

Wendt India Ltd Q3 consolidated PAT falls to Rs. 2.20 crore

Faze Three Autofab Ltd Q3 net profit at Rs. 0.48 crore

Emkay Global Financial Services Ltd Q3 loss at Rs. 1.41 crore

ION Exchange India Ltd consolidated Q3 PAT higher at Rs. 26.31 crore

Shree Bhavya Fabrics Ltd posts net profit of Rs. 0.77 crore in Q3

Mangalam Drugs & Organics Ltd Q3 PAT jumps to Rs. 1.65 crore

ARO Granite Industries Ltd Q3 net profit at Rs. 0.65 crore

JSW Steel Ltd consolidated Q3 PAT declines to Rs. 211 crores

Udaipur Cement Works Ltd posts PAT of Rs. 0.97 crore in Q3

Strides announces successful completion of US FDA inspection at its Alathur facility with Zero 483 observations

Sonata Software Ltd reports Rs.75.86 crores net profit in Q3 FY20

Oriental Hotels Ltd posts consolidated PAT of Rs. 7.31 crore

Kirloskar Ferrous Industries Ltd Q3 PAT increases QoQ to Rs. 23.33 crore

Indian Bank reports Q3 net profit of Rs. 247.16 crore

Sunil Agro Foods Ltd posts net profit of Rs. 0.14 crore in Q3

Triumph Motorcycles and Bajaj Auto commence their global partnership

AMJ Land Holdings Ltd reports consolidated profit of Rs. 4 crore in Q3

Onward Technologies Ltd Q3 net profit drops QoQ, YoY

Oriental Veneer Products Ltd Q3 consolidated PAT jumps to Rs. 8.71 crore

USFDA conducts surprise audit at bioanalytical facility of Jeevan Scientific Technology Ltd

ULTRATECH Cement Ltd Q3 consolidated net profit soars to Rs. 711.25 crores

CG-VAK Software & Exports Ltd Q3 consolidated PAT rises to Rs. 0.94 crore

Atishay Ltd bags work order

ATUL Ltd consolidated Q3 net profit declines QoQ

AAVAS Financiers Ltd Q3 consolidated PAT drops QoQ to Rs. 67.92 crore

NLC India Ltd to raise Rs. 525 crore

Supreme Industries Ltd reports consolidated PAT of Rs. 123.39 crores in Q3

HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos

A true symbol of Make in India, Maruti Suzuki commences exports of its blockbuster model S-PRESSO

Allahabad Bank board approves capital infusion of Rs. 2153 crore

TCS Named a Leader in Talent Readiness for Next-generation IT Services by Everest Group

Strides receives USFDA tentative approval for Triamcinolone Acetonide Ointment

Alembic Pharmaceuticals announces USFDA Final Approval for Bosentan Tablets, 62.5 mg and 125 mg

Blue Star wins the prestigious 'Golden Peacock Award for Corporate Ethics' for 2019

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019